Advertisement

Tropicamide 1% Ophthalmic Solution

[10 May 2016]

Products Affected - Description

Mydriacyl ophthalmic solution, Alcon Labs
1%, 3 mL bottle, 1 count (NDC 00065-0355-03)

Reason for the Shortage

  • Akorn has tropicamide 1% ophthalmic solution available.
  • Alcon could not provide a reason for the shortage of Mydriacyl.
  • Valeant has tropicamide 1% ophthalmic solution available.

Available Products

Mydriacyl ophthalmic solution, Alcon Labs
1%, 15 mL bottle, 1 count (NDC 00065-0355-15)
 
Tropicamide ophthalmic solution, Akorn
1%, 15 mL bottle, 1 count (NDC 17478-0102-12)
 
Tropicamide ophthalmic solution, Sandoz
1%, 3 mL bottle, 1 count (NDC 61314-0355-01)
1%, 15 mL bottle, 1 count (NDC 61314-0355-02)
 
Tropicamide ophthalmic solution, Valeant
1%, 2 mL bottle, 1 count (NDC 24208-0585-59)
1%, 15 mL bottle, 1 count, NDC 24208-0585-64

Estimated Resupply Dates

Alcon has Mydriacyl 1% 3 mL bottles on back order and the company estimates a release date in early-June 2016.

Related Shortages

Updated

May 10, April 18, March 8, February 25, January 14, 2016; December 22 and 15, November 18, October 23, 2015, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing